Literature DB >> 4357685

A suppression of cellular immunity in patients with multiple sclerosis.

V Utermohlen, J B Zabriskie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4357685      PMCID： PMC2139461          DOI： 10.1084/jem.138.6.1591

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


× No keyword cloud information.
  8 in total

1.  Measles antibodies in multiple sclerosis.

Authors:  J M ADAMS; D T IMAGAWA
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

2.  Measles antibodies in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  P Brown; F Cathala; D C Gajdusek; C J Gibbs
Journal:  Proc Soc Exp Biol Med       Date:  1971-07

3.  HL-A antigen frequencies in multiple sclerosis. Significant increase of HL-A3, HL-A10 and W5, and decrease of HL-A12.

Authors:  J Bertrams; E Kuwert
Journal:  Eur Neurol       Date:  1972       Impact factor: 1.710

4.  Cellular interactions in the leukocyte migration inhibition system.

Authors:  S E Read; J B Zabriskie
Journal:  Transplant Proc       Date:  1972-06       Impact factor: 1.066

5.  Lymphocytic responses to streptococcal antigens in glomerulonephritic patients.

Authors:  J B Zabriskie; R Lewshenia; G Möller; B Wehle; R E Falk
Journal:  Science       Date:  1970-05-29       Impact factor: 47.728

6.  Specific inhibition of the in vitro migration of leucocytes in ulcerative colitis and Crohn's disease.

Authors:  G Bendixen
Journal:  Scand J Gastroenterol       Date:  1967       Impact factor: 2.423

7.  Paramyxovirus-like particles associated with acute demyelination in chronic relapsing multiple sclerosis.

Authors:  J Prineas
Journal:  Science       Date:  1972-11-17       Impact factor: 47.728

8.  REACTIONS OF RABBITS TO NON-HEMOLYTIC STREPTOCOCCI : III. A STUDY OF MODES OF SENSITIZATION.

Authors:  C L Derick; C H Hitchcock; H F Swift
Journal:  J Exp Med       Date:  1930-06-30       Impact factor: 14.307
  8 in total
  22 in total

1.  Surface markers on lymphocytes of multiple sclerosis patients.

Authors:  J Nowak; A Wajgt
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

2.  Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families.

Authors:  S M Fu; R Stern; H G Kunkel; B Dupont; J A Hansen; N K Day; R A Good; C Jersild; M Fotino
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

3.  Demonstration of T-cell and K-cell cytotoxicity against measles-infected cells in normal subjects, multiple sclerosis and subacute sclerosing panencephalitis.

Authors:  P W Ewan; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

4.  A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.

Authors:  R C Collins; L R Espinoza; C R Plank; G C Ebers; R A Rosenberg; J B Zabriskie
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

5.  Editorial: Transfer factor.

Authors: 
Journal:  Br Med J       Date:  1974-05-25

6.  Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.

Authors:  J R Kateley; S J Bazzell
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

7.  Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis.

Authors:  P A Neighbour; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

8.  Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology.

Authors:  D C Poskanzer; J L Sheridan; L B Prenney; A M Walker
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

9.  Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.

Authors:  W Sheremata; A Sazant; G Watters
Journal:  Can Med Assoc J       Date:  1978-03-04       Impact factor: 8.262

10.  Immunological features in multiple sclerosis.

Authors:  G Lamoureux; N Giard; R Jolicoeur; V Toughlian; M Desrosiers
Journal:  Br Med J       Date:  1976-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.